Latest News from the Lupus Research Institute

Large Scale Study Reinforces Link Between Mood Disorders and Autoimmune Diseases Like Lupus

Fri, 14 Jun 2013 11:08:37 -0500

Published results of a recent study provide further evidence of a link between autoimmune diseases like lupus and mood disorders. An analysis of more than 3.5 million people in Denmark showed that the risk of developing a mood disorder was higher among people who had been hospitalized due to an autoimmune disease. Hospitalization due to a severe infection was another strong risk factor for a mood disorder.

New Research on Investigational Lupus Drug Epratuzumab

Fri, 14 Jun 2013 09:27:47 -0500

New research presented at a major European medical meeting provided insight into how the investigational drug epratuzumab may be effective in lupus. Epratuzumab is currently in late stage Phase III trials for its use in lupus.

Urgent Action Needed by New York Lupus Community

Thu, 13 Jun 2013 20:16:41 -0500

The NYS Lupus Tax Check-off bill needs your urgent attention! This bill would list lupus as a tax check-off box on the NYS Tax Return to receive funds for lupus programs.

It is critical that calls be made by 5pm today to the Chair of the Senate Rules Committee, Senator Tom Libous at both 518-455-2677 and 607-773-8771.

Thank you.

When you call: "State your name, how lupus affects you, and ask Senator Libous to please put S-2777, the Lupus Taxpayer Check-off bill, on the Rules agenda and move it to the floor for a vote."

Q&A on Major Progress in Lupus Research

Thu, 13 Jun 2013 13:13:45 -0500

The digital edition of the Autoimmune Awareness Supplement to the Washington Post includes this Q&A session with LRI’s President Margaret Dowd on what lupus research is achieving. Strides in predicting lupus flares and heart risk; discovering how lupus attacks the brain and the heart; and improving diagnosis of kidney damage are among the many discoveries Ms. Dowd shares. She also answers questions about better treatments on the horizon and why a cure for lupus may be within reach.

Autoimmunity and Lupus Headline Today’s Washington Post Supplement

Wed, 12 Jun 2013 12:11:06 -0500

Lupus got major ink in a supplement devoted to autoimmune disease in the Washington Post June 12 newspaper. The need for improved diagnosis of lupus and other autoimmune diseases was highlighted by our own LRI President Margaret Dowd in a feature article on the Lupus Initiative, a new federal program training healthcare professionals to recognize and treat the disease promptly.

Investigational Drug Laquinimod Helped Treat Lupus Nephritis in Phase 2 Trial

Wed, 12 Jun 2013 09:20:41 -0500

Results of a Phase 2 trial showed that the investigational drug laquinimod improved kidney function in patients with lupus nephritis. The data was reported today at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology in Madrid.

LRI Shines New Light on Lupus with New Progress, New Momentum and New Hope

Wed, 05 Jun 2013 12:41:10 -0500

U.S. Senator Frank Lautenberg Dies – A Deep Loss To Lupus Patients Nationwide

Mon, 03 Jun 2013 15:32:27 -0500

We at the S.L.E. Lupus Foundation and Lupus Research Institute say goodbye with deep sadness and great appreciation to U.S. Senator Frank Lautenberg (D-N.J.), who died June 3, 2013 at 89 years of age. A devoted friend to both our organizations, he led the fight in the U.S. Senate and House of Representatives to make lupus a national health priority.

U.S. Senator Frank Lautenberg Dies – A Deep Loss To Lupus Patients Nationwide

Mon, 03 Jun 2013 10:21:46 -0500

LRI Advocacy Ambassador Speaks at New York Biotechnology Association

Mon, 03 Jun 2013 09:18:00 -0500

Latest News from the Lupus Research Institute

Large Scale Study Reinforces Link Between Mood Disorders and Autoimmune Diseases Like Lupus

New Research on Investigational Lupus Drug Epratuzumab

Urgent Action Needed by New York Lupus Community

Q&A on Major Progress in Lupus Research

Autoimmunity and Lupus Headline Today’s Washington Post Supplement

Investigational Drug Laquinimod Helped Treat Lupus Nephritis in Phase 2 Trial

LRI Shines New Light on Lupus with New Progress, New Momentum and New Hope

U.S. Senator Frank Lautenberg Dies – A Deep Loss To Lupus Patients Nationwide

U.S. Senator Frank Lautenberg Dies – A Deep Loss To Lupus Patients Nationwide

LRI Advocacy Ambassador Speaks at New York Biotechnology Association

Lupus Research Institute Advocacy Ambassador Featured Speaker at New York Biotechnology Association Annual Meeting